ArticleCureus2025
Molecular Characterization of Primary Ovarian Angiosarcoma in a Patient With a History of Mature Ovarian Teratoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiosarcomas of the female reproductive tract are rare, most commonly occurring in the uterine body, and especially rare in the ovaries. Furthermore, the concomitance of angiosarcomas and mature cystic teratomas of the same ovary is even more sparse. We report a case of a 34-year-old G2P2 female with angiosarcoma of the left ovary, approximately 12 years after an initial diagnosis of mature cystic teratoma of bilateral ovaries with molecular and next-generation sequencing (NGS) studies supporting the diagnoses of two distinct primaries. Our case is unique as comparative NGS and copy-number mutation studies established that the two lesions are not genetically related, favoring distinct tumors that may be helpful in guiding therapeutic management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.